James Garsteck is an accomplished inventor based in Scottsdale, PA (US). He has made significant contributions to the field of respiratory therapy, particularly in the development of systems and methods for improving cough segmentation. With a total of 2 patents, his work focuses on enhancing the effectiveness of cough control mechanisms.

Latest Patents

Garsteck's latest patents include innovative technologies aimed at improving cough management. The first patent, titled "System and methods for improved cough segmentation," describes a system that controls the opening and closing of a valve to establish fluid communication between the airway of the subject and atmospheric pressure. This system allows for multiple openings and closings of the valve during individual exhalations, adjusting based on the pressure level in or near the airway.

The second patent, "Secretion loosening and cough segmenting therapy," outlines a system that comprises a subject interface, a segmenter, a loosener, sensors, and computer processors. The segmenter selectively controls gas flow to provide high amplitude pressure oscillations during exhalation, aiding cough productivity. Meanwhile, the loosener provides low amplitude pressure oscillations during inhalation and exhalation to help loosen respiratory secretions. The computer processors detect trigger events and control the system accordingly.

Career Highlights

James Garsteck is currently employed at Koninklijke Philips Corporation N.V., where he continues to innovate in the field of respiratory health. His work has the potential to significantly improve the quality of life for individuals with respiratory issues.

Collaborations

Garsteck collaborates with notable colleagues, including Maarten Leonardus Christian Brand and Anandi Mahadevan, who contribute to the development and refinement of his innovative systems.

Conclusion

James Garsteck's contributions to cough therapy through his patents demonstrate his commitment to advancing respiratory health technologies. His innovative approaches have the potential to transform how cough management is approached in clinical settings.